Global CRO Veristat Partners Up With TrialHub To Perform Best-In-Class Feasibility And Site Selection

Veristat, a global full-service impact clinical research organization (CRO) headquartered in Southborough, MA, and FindMeCure Ltd, a technology company based in the UK, are announcing today a partnership aiming to bring clinical trials closer to patients.

With expertise in vaccine and Ebola clinical trials, Veristat is a preferred partner for running COVID-19 studies.

Last year they announced several strategic acquisitions that have strengthened their positions not only across Europe, but worldwide.

“In order to respond to the rising demand coming from small and medium biopharmaceutical companies, we needed a new scalable way to assess the dynamics of each clinical trial landscape. Our goal is to perform best-in-class feasibility and site selection in order to prevent delays and ensure smooth clinical trial operations. This is why we decided to partner up with FindMeCure and their TrialHub – a data-on-demand platform combining feasibility with patient recruitment analysis.” stated Shaheen Limbada, VP Global Clinical Operations at Veristat.

“On our side, we are looking to amend our algorithms to Veristat’s projects and know-how in order to speed up clinical trial feasibility, as well as project best scenarios for their global clinical trials” stated Maya Zlatanova, CEO and Co-founder of FindMeCure Ltd.

She also noted this partnership is coming at a key moment for both companies, as COVID-19 accelerated the adoption of virtual clinical trial components and FindMeCure released the first global database of investigators with experience in virtual and hybrid studies. TrialHub is also working towards additional features to support decision making around decentralized clinical trial technology deployment in different countries.

TrialHub is a feasibility and patient recruitment cloud-based platform that covers information on all indications in 70 countries. The system structures thousands of data sources about patients, regulations, and sites to predict clinical trial operations and budgets.

TrialHub also relies on a network of local experts to anticipate any country-related challenges and identify opportunities for speeding up patient recruitment.

First published on Clinical Leader.

Scroll to Top